Drug
U-13C-glucose
U-13C-glucose is a pharmaceutical drug with 3 clinical trials. Currently 3 active trials ongoing.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Active Trials
3(100%)
Phase Distribution
Ph not_applicable
1
33%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
3
trials recruiting
Total Trials
3
all time
Status Distribution
Active(3)
Detailed Status
Recruiting3
Development Timeline
Analytics
Development Status
Total Trials
3
Active
3
Success Rate
N/A
Most Advanced
N/A
Trials by Phase
N/A1 (100.0%)
Trials by Status
recruiting3100%
Recent Activity
3 active trials
Showing 3 of 3
recruitingnot_applicable
Investigating the Metabolic Pathways in Hormone Receptor Positive/HER2 Negative Breast Cancer
NCT05736367
recruiting
In Vivo Metabolic Profiling of CLL (Chronic Lymphocytic Leukemia)
NCT04785989
recruiting
13C-Glucose Tracing of Tumour and T Cells in the Ascites of Ovarian Cancer Patients.
NCT05025878
Clinical Trials (3)
Showing 3 of 3 trials
NCT05736367Not Applicable
Investigating the Metabolic Pathways in Hormone Receptor Positive/HER2 Negative Breast Cancer
NCT04785989
In Vivo Metabolic Profiling of CLL (Chronic Lymphocytic Leukemia)
NCT05025878
13C-Glucose Tracing of Tumour and T Cells in the Ascites of Ovarian Cancer Patients.
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3